Pharmaceutical Technology

DECEMBER 20, 2023

The FDA accepted the filing based on NIH-funded Phase III trial interim results, with an approval decision expected in Q1 2024

Allergies 244

Allergies Trials 244

BioTech 365

NOVEMBER 18, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Tackling food allergies at the source.Food allergies are a big problem. About 7% of children and 2% of adults in the U.S. suffer from some kind of … Continue reading →

Allergies 40

Allergies Research 40

Drug Discovery World

OCTOBER 13, 2022

New research has shown that standard cat allergy treatment can be enhanced to make it more effective and faster acting, and the benefits last for a year after treatment ends. The findings of the study, supported by the National Institutes of Health, were published in the Journal of Allergy and Clinical Immunology. .

Allergies 52

Allergies Gene Antibody Trials 52

Scienmag

DECEMBER 7, 2021

In an analysis of data on 1,303 healthy infants who were exclusively breastfed until at least 3 months of age, 38% and 74% of infants had multiple mild-to-moderate milk allergy symptoms—as defined by current allergy guidelines—at 3 months and 12 months old, respectively.

Allergies 64

Allergies 64

XTalks

NOVEMBER 4, 2020

It has long been known that mothers greatly influence the development of the growing fetus by not only providing nutrients through the placenta, but also a growing list of biological elements including beneficial antibodies, gut bacteria and now, allergies. Related: Red Meat Allergy Test Gets FDA Clearance.

Allergies 98

Allergies Antibody In-Vitro Development 98

The Pharma Data

DECEMBER 13, 2020

Consumer News. Avoid Allergy Flare-Ups This Holiday Season. But indoor allergies could also take the joy out of your holiday season, an expert says. “Dust provides shelter for things that cause allergies, like mites and fungi, which are major components of dust themselves,” he said in a college news release.

Allergies 52

Allergies Doctors Doctor Medicine 52

XTalks

JUNE 21, 2021

who is on a mission to help parents save their children from food allergies by providing them with a powder added to their milk bottles. Zakowski started this company because his nephew developed several severe food allergies. Related: Red Meat Allergy Test Gets FDA Clearance. The product is part of a three-step guidance system.

Allergies 98

Allergies Production FDA Approval Protein 98

The Pharma Data

DECEMBER 26, 2020

Consumer News. Resolve to Keep Your Asthma, Allergies Under Control in 2021. 26, 2020 — If you have allergies or asthma, keeping them under control might be a good New Year’s resolution, experts suggest. Can you think of a better way to ring in the new year?” More News Resources.

Allergies 52

Allergies 52

Pharmaceutical Technology

JULY 26, 2023

Intrommune Therapeutics has completed the last patient last visit for its desensitisation candidate INT301.

Allergies 130

Allergies Trials 130

Delveinsight

DECEMBER 23, 2020

As per the Food Allergy Research & Education, in the US, each year, around 200,000 people require emergency medical care for allergic reactions to food. Food allergy is a specific immune response to certain food items that it considers harmful. The symptoms of food allergy vary from person to person and can also differ over time.

Allergies 52

Allergies Immune Response Production Development 52

pharmaphorum

OCTOBER 27, 2021

AIT involves the administration of controlled, low doses of allergens under the tongue or by subcutaneous injection in people with allergies, with the aim of desensitising the immune system to them and prevent allergic reactions. ” The post Allergy specialist Stallergenes taps Aptar for digital delivery appeared first on.

Allergies 62

Allergies Drug Delivery Development Marketing 62

pharmaphorum

DECEMBER 10, 2020

Moncef Slaoui, co-head of the US government’s Operation Warp Speed COVID-19 vaccine programme, made the comments after the UK drugs regulator advised those with severe allergies to avoid the vaccine. The post Coronavirus vaccine may have allergy warning in US, says expert appeared first on.

Allergies 81

Allergies Vaccination Vaccine Regulation 81

The Pharma Data

DECEMBER 18, 2020

ACAAI: Reaction to COVID-19 Vaccine Unlikely for Those With Common Allergies. Members of the task force say that individuals with common allergies to medications, foods, inhalants, insects, and latex are no more likely than the general public to have an allergic reaction to the Pfizer-BioNTech COVID-19 vaccine. More News Resources.

Allergies 52

Allergies Vaccination Vaccine Immune Response 52

Pharma Times

FEBRUARY 8, 2024

The cell could be a target for new immunotherapies for the chronic disease

Allergies 111

Allergies Research 111

The Pharma Data

JANUARY 7, 2021

This clearance is a pivotal regulatory milestone that further supports Camallergy’s leadership and capabilities in the field of peanut allergy immunotherapy with the only cGMP-certified manufacturing facility in Europe producing peanut oral immunotherapy,” said Sherden Timmins, Chief Technology Officer. 8, 2021 07:00 UTC. About Camallergy.

Allergies 52

Allergies Manufacturing Production Clinical Trials 52

The Pharma Data

JANUARY 4, 2021

4, 2021 — Mothers who drink cow’s milk while breastfeeding may reduce their child’s risk of developing food allergies , a new Swedish study suggests. The findings held after the researchers took into account other factors known to increase allergy risk in children, such as genetics. MONDAY, Jan.

Allergies 52

Allergies Doctors Doctor Dermatology 52

pharmaphorum

AUGUST 5, 2020

DBV Technologies’ long and tortuous path to an FDA verdict on its Viaskin Peanut allergy shot has led to another dead end. The rationale behind Viaskin Peanut is to expose people with peanut allergy to small, rising amounts of peanut protein – which acts as an allergen – to encourage the immune system to develop tolerance over time.

Allergies 52

Allergies Production Clinical Trials Clinical Trials 52

Pharmaceutical Technology

OCTOBER 12, 2023

The Phase III trial of ALK’s allergy immunotherapy tablet met its primary endpoint for the treatment of tree-pollen-induced allergics.

Trials 147

Trials Allergies 147

BioTech 365

JANUARY 27, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Making wheat and peanuts less allergenic.The United States Department of Agriculture identifies a group of “big eight” foods that causes 90% of food allergies.

Allergies 40

Allergies Research 40

Drug Discovery World

JUNE 30, 2023

News round-up for 26-30 June by DDW Digital Content Editor Diana Spencer. This week we have heard about a number of studies that demonstrate an inventive solution to an old problem, either through the use of an original approach or new, advanced technology. The top stories: Could a monoclonal antibody treat peanut allergy?

Allergies 52

Allergies Drugs Antibody Regulation 52

Pharmaceutical Technology

MARCH 20, 2023

The partnership will focus on developing potential new vaccines to treat certain selected autoimmune indications, as well as food allergies. The mRNA vaccine candidates will help reduce the chances of autoimmune responses that might lead to allergic conditions or serious autoimmune diseases.

Vaccination 245

Vaccination Vaccine Development Allergies 245

Drug Discovery World

MARCH 1, 2024

News round-up for 26 Feb – 1 March by DDW Digital Content Editor Diana Spencer. The news highlights this week all focus on regulatory decisions, both positive and negative.

Drugs 52

Drugs Allergies FDA Approval Medicine 52

STAT News

JANUARY 18, 2023

The National Institute of Allergy and Infectious Diseases reported Wednesday that a Phase 3 clinical trial of a vaccine was stopped because the vaccine was ineffective at preventing HIV infection. Yet another experimental HIV vaccine has failed. The vaccine was being developed by Janssen, the vaccine division of Johnson & Johnson.

Clinical Trials 145

Clinical Trials Clinical Trials Vaccination Vaccine 145

XTalks

DECEMBER 20, 2023

Xtalks compiled a list of its top life science news and trends of 2023, which provided readers with the latest developments, information and expert insights across life science industries, including pharma, biotech and medical device. Read on to see our editorial team’s top news picks of the year. billion ad impressions.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

XTalks

SEPTEMBER 28, 2023

Related: Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate Bayer’s new over-the-counter (OTC) cold, flu and allergy med Astepro not only emerged as the most viewed new pharma TV ad in the first half of the year, but also topped iSpot.tv’s list of all new brand ads with 7.4

Drugs 105

Drugs Allergies Branding FDA Approval 105

Scienmag

SEPTEMBER 18, 2020

This year’s groundbreaking allergy and asthma news will be delivered virtually, and for free. Every year you rely on the American College of Allergy, Asthma and Immunology’s Annual Scientific Meeting to deliver the most recent updates on what is happening in the world of allergy and asthma research and treatment.

Allergies 40

Allergies Research Medicine 40

STAT News

MARCH 13, 2023

An algorithm, not a doctor, predicted a rapid recovery for Frances Walter, an 85-year-old Wisconsin woman with a shattered left shoulder and an allergy to pain medicine. days, it estimated, she would be ready to leave her nursing home.

Allergies 145

Allergies Nurses Doctors Doctor 145

Delveinsight

AUGUST 6, 2020

FDA turns back peanut allergy patch of DBV Technologies. A peanut allergy patch which is based on new delivery technology has hit a snag at the FDA. These antibodies defend a cell from infection by squarely preventing the pathogen’s biological activities. The agency raised no safety concerns.

Allergies 53

Allergies Vaccination Vaccine Gene Therapy 53

Scienmag

FEBRUARY 26, 2022

Peanut allergies are hard to treat and can cause fatal or near-fatal anaphylactic reactions. People usually don’t outgrow peanut allergy, requiring lifelong scrutiny of food labels to avoid even small traces of peanut.

Allergies 75

Allergies Clinical Trials Clinical Trials Trials 75

Scienmag

JULY 7, 2022

New research published in Clinical and Experimental Allergy reveals that prescriptions of specialized infant formula have increased in recent years in England, Norway, and Australia, with rates over 10-fold what would be expected for the number of children with milk allergies. fold in England from 2007–2018, with […].

Allergies 66

Allergies Research 66

STAT News

SEPTEMBER 2, 2022

” At best, it’s a request for a recommendation for a gynecologist or for advice on which antihistamine works best for allergies. The most uncomfortable one is “doctor friend.” But other times I have found myself in the role of interpreter between a friend and their physician, navigating serious health problems.

Doctors 116

Doctors Doctor Allergies 116

Drug Channels

MARCH 31, 2021

Spring has finally reached our worldwide headquarters here in lovely downtown Philadelphia. See photo at right.)

Allergies 52

Allergies Drugs Pharmacy 52

XTalks

JUNE 23, 2021

Seed-based foods are not only allergy-friendly but also have a strong nutritional profile, loaded with protein, vitamins and minerals. Chicago-based startup Blake’s Seed Based was founded in 2018 by Blake Sorenson, an athlete with a deathly nut allergy who was looking for an alternative to nut-containing snacks. Blake’s Seed Based.

Allergies 92

Allergies Containment Branding Production 92

Pharma Mirror

DECEMBER 1, 2021

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, sponsored a randomized, double-blind, placebo-controlled clinical trial that included 969. The post Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19 appeared first on Pharma Mirror Magazine.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Allergies 130

Pharmaceutical Technology

SEPTEMBER 16, 2022

These results are in line with those obtained from the placebo-controlled, double-blind ACTT-1 trial of the National Institute of Allergy and Infectious Diseases. A nucleotide analog, Veklury hinders viral replication in the cell by acting on the RNA polymerase of the SARS-CoV-2 virus.

Allergies 277

Allergies RNA Clinical Trials Clinical Trials 277

Pharmaceutical Technology

MAY 16, 2023

The deal allows Juno to provide medical practitioners and patients with new critical pharmaceutical products. The firm plans to offer more than 100 new products to the Canadian market in the next four years, with pain management, oral solutions, allergy vaccines, diabetes and weight loss as the main areas of focus.

Cosmetics 130

Cosmetics Allergies Manufacturing Production 130

STAT News

AUGUST 22, 2022

Fauci, 81, has led the National Institute of Allergy and Infectious Diseases for 38 years, serving a line of presidents from both parties since the Reagan administration. Anthony Fauci, the top U.S. He has also served as President Biden’s chief medical adviser since Biden took office.

Allergies 98

Allergies Research 98